ID OV-2008 AC CVCL_0473 AS CVCL_4066 SY OV2008; Ov2008; OV 2008; 2008; A2008 DR BTO; BTO_0003792 DR EFO; EFO_0022702 DR MCCL; MCC:0000371 DR BioSample; SAMN03151841 DR BioSample; SAMN03151843 DR cancercelllines; CVCL_0473 DR ChEMBL-Cells; CHEMBL3308015 DR ChEMBL-Targets; CHEMBL612818 DR Cosmic; 849613 DR Cosmic; 948293 DR Cosmic; 988874 DR Cosmic; 1102825 DR Cosmic; 1524359 DR Cosmic; 1707563 DR Cosmic; 2582806 DR Cosmic; 2674703 DR GEO; GSM184384 DR GEO; GSM184385 DR GEO; GSM659387 DR GEO; GSM711715 DR GEO; GSM711718 DR GEO; GSM851907 DR GEO; GSM851925 DR IARC_TP53; 25074 DR Progenetix; CVCL_0473 DR PubChem_Cell_line; CVCL_0473 DR Wikidata; Q54936825 RX PubMed=4118903; RX PubMed=9234707; RX PubMed=11314036; RX PubMed=19926575; RX PubMed=22710073; RX PubMed=24023729; RX PubMed=25846456; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx WW Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-62.html CC Problematic cell line: Contaminated. Shown to be a ME-180 derivative (PubMed=22710073). Originally thought to originate from a female patient with an ovarian serous carcinoma. CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00466. CC Population: Caucasian. CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=25846456). CC Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68). CC Omics: Transcriptomics; Microarray. CC Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688. ST Source(s): PubMed=22710073 ST Amelogenin: X ST CSF1PO: 11 ST D13S317: 11,12 ST D16S539: 12,13 ST D18S51: 12 ST D19S433: 13,15.2 ST D21S11: 30,31 ST D2S1338: 18 ST D3S1358: 16 ST D5S818: 12 ST D7S820: 9,10 ST D8S1179: 14 ST FGA: 23 ST TH01: 8,9.3 ST TPOX: 8,10 ST vWA: 15,17 DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma DI ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_1401 ! ME-180 SX Female AG 66Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 35 CH CVCL_0114 ! 2008/C13*5.25 CH CVCL_W373 ! PX2 CH CVCL_W374 ! PX24 // RX PubMed=19926575; DOI=10.1309/AJCPTK87EMMIKPFS; PMCID=PMC3040237; RA DeRycke, Melissa S. RA Andersen, John D. RA Harrington, Katherine M. RA Pambuccian, Stefan Eduard RA Kalloger, Steve E. RA Boylan, Kristin L.M. RA Argenta, Peter Alexander RA Skubitz, Amy Patrice Norden RT "S100A1 expression in ovarian and endometrial endometrioid carcinomas RT is a prognostic indicator of relapse-free survival."; RL Am. J. Clin. Pathol. 132:846-856(2009). // RX PubMed=25846456; DOI=10.3892/ijo.2015.2951; RA Takenaka, Masataka RA Saito, Motonobu RA Iwakawa, Reika RA Yanaihara, Nozomu RA Saito, Misato RA Kato, Mamoru RA Ichikawa, Hitoshi RA Shibata, Tatsuhiro RA Yokota, Jun RA Okamoto, Aikou RA Kohno, Takashi RT "Profiling of actionable gene alterations in ovarian cancer by RT targeted deep sequencing."; RL Int. J. Oncol. 46:2389-2398(2015). // RX PubMed=22710073; DOI=10.1016/j.ygyno.2012.06.017; PMCID=PMC3432677; RA Korch, Christopher T. RA Spillman, Monique Ann RA Jackson, Twila A. RA Jacobsen, Britta M. RA Murphy, Susan K. RA Lessey, Bruce Arthur RA Jordan, Virgil Craig RA Bradford, Andrew Peter RT "DNA profiling analysis of endometrial and ovarian cell lines reveals RT misidentification, redundancy and contamination."; RL Gynecol. Oncol. 127:241-248(2012). // RX PubMed=24023729; DOI=10.1371/journal.pone.0072162; PMCID=PMC3762837; RA Anglesio, Michael S. RA Wiegand, Kimberly C. RA Melnyk, Nataliya RA Chow, Christine RA Salamanca, Clara M. RA Prentice, Leah M. RA Senz, Janine RA Yang, Winnie RA Spillman, Monique Ann RA Cochrane, Dawn R. RA Shumansky, Karey RA Shah, Sohrab P. RA Kalloger, Steve E. RA Huntsman, David G. RT "Type-specific cell line models for type-specific ovarian cancer RT research."; RL PLoS ONE 8:e72162.1-e72162.13(2013). // RX PubMed=9234707; DOI=10.1128/mcb.17.8.4501; PMCID=PMC232303; RA Bullions, Linda C. RA Notterman, Daniel A. RA Chung, Lorinda S. RA Levine, Arnold Jay RT "Expression of wild-type alpha-catenin protein in cells with a mutant RT alpha-catenin gene restores both growth regulation and tumor RT suppressor activities."; RL Mol. Cell. Biol. 17:4501-4508(1997). // RX PubMed=4118903; DOI=10.1016/0002-9378(72)90109-3; RA DiSaia, Philip J. RA Sinkovics, Joseph G. RA Rutledge, Felix Noah RA Smith, Julian P. RT "Cell-mediated immunity to human malignant cells. A brief review and RT further studies with two gynecologic tumors."; RL Am. J. Obstet. Gynecol. 114:979-989(1972). // RX PubMed=11314036; DOI=10.1038/sj.onc.1204211; RA Forgacs, Eva RA Wren, Jonathan D. RA Kamibayashi, Craig RA Kondo, Masashi RA Xu, Xie L. RA Markowitz, Sanford David RA Tomlinson, Gail E. RA Muller, Carolyn Y. RA Gazdar, Adi F. RA Garner, Harold Ray RA Minna, John D. RT "Searching for microsatellite mutations in coding regions in lung, RT breast, ovarian and colorectal cancers."; RL Oncogene 20:1005-1009(2001). //